The Klinique Med Stock Last Dividend Paid
| KLINIQ Stock | 30.75 0.25 0.82% |
The Klinique Med fundamentals help investors to digest information that contributes to Klinique Med's financial success or failures. It also enables traders to predict the movement of Klinique Stock. The fundamental analysis module provides a way to measure Klinique Med's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Klinique Med stock.
Klinique |
The Klinique Med Company Last Dividend Paid Analysis
Klinique Med's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Current Klinique Med Last Dividend Paid | 0.43 |
Most of Klinique Med's fundamental indicators, such as Last Dividend Paid, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, The Klinique Med is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
| Competition |
Based on the recorded statements, The Klinique Med has a Last Dividend Paid of 0.426. This is much higher than that of the Consumer Cyclical sector and significantly higher than that of the Personal Services industry. The last dividend paid for all Thailand stocks is notably lower than that of the firm.
Did you try this?
Run Theme Ratings Now
Theme RatingsDetermine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Klinique Fundamentals
| Return On Equity | 0.95 | |||
| Return On Asset | 0.12 | |||
| Profit Margin | 0.13 % | |||
| Operating Margin | 0.17 % | |||
| Current Valuation | 9.44 B | |||
| Shares Outstanding | 220 M | |||
| Shares Owned By Insiders | 73.66 % | |||
| Price To Book | 39.18 X | |||
| Price To Sales | 5.73 X | |||
| Revenue | 1.49 B | |||
| Gross Profit | 558.77 M | |||
| EBITDA | 288.81 M | |||
| Book Value Per Share | 0.95 X | |||
| Earnings Per Share | 1.09 X | |||
| Target Price | 44.5 | |||
| Market Capitalization | 7.81 B | |||
| Last Dividend Paid | 0.43 |
About Klinique Med Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze The Klinique Med's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Klinique Med using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of The Klinique Med based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Klinique Stock
Klinique Med financial ratios help investors to determine whether Klinique Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Klinique with respect to the benefits of owning Klinique Med security.